申请人:Gerlach Matthias
公开号:US20090275534A1
公开(公告)日:2009-11-05
The invention relates to pyrido[2,3-b]pyrazine compounds of general formulae (Ia) and (Ib), to their preparation and use, for example, for the treatment of malignant disorders and other disorders based on pathological cell proliferations.
本发明涉及一般式(Ia)和(Ib)的吡啶并[2,3-b]吡嗪类化合物,以及它们的制备和用途,例如用于治疗恶性疾病和其他基于病理细胞增殖的疾病。